• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TUBB3 在尿路上皮癌中的临床病理意义及其在尿液细胞学中的可能应用。

Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology.

机构信息

Laboratory of Molecular Pathology, Department of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima, Japan.

Department of Pathology, Kure-Kyosai Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Hiroshima, Japan.

出版信息

Pathol Int. 2023 Sep;73(9):444-455. doi: 10.1111/pin.13362. Epub 2023 Aug 17.

DOI:10.1111/pin.13362
PMID:37589430
Abstract

βIII-Tubulin, encoded by the TUBB3 gene, is a microtubule protein. We previously reported that TUBB3 is overexpressed in renal cell carcinoma. We investigated the clinicopathological significance of TUBB3 in upper tract urothelial carcinoma (UTUC) by immunohistochemistry. In normal tissue, TUBB3 expression was weak or absent. In contrast, TUBB3 overexpression was observed in urothelial carcinoma (UC) tissues in 51 (49%) of 103 UTUC cases. TUBB3 overexpression was associated with nodular/flat morphology, high-grade disease, high T stage, and a poor prognosis. Similar results were obtained in The Cancer Genome Atlas bladder cancer cohort. TUBB3 expression was also associated with high Ki-67 labeling index, CD44v9, HER2, EGFR, and p53 expression in UTUC. Among representative cancer-related molecules, TUBB3 was an independent predictor of progression-free survival and high-grade UC. Finally, using urine cytology samples, we analyzed TUBB3 expression by immunocytochemistry. TUBB3 expression was more frequently found in UC cells than in nonneoplastic cells. The diagnostic accuracy of urine cytology was improved when combined with TUBB3 immunostaining. The findings suggest the importance of TUBB3 in tumor progression and its potential application as a biomarker for high-grade disease and the prognosis of UC. Moreover, combination with TUBB3 immunostaining might improve the diagnostic accuracy of urine cytology.

摘要

βIII-微管蛋白,由 TUBB3 基因编码,是一种微管蛋白。我们之前报道过 TUBB3 在肾细胞癌中过度表达。我们通过免疫组织化学方法研究了 TUBB3 在尿路上皮癌(UTUC)中的临床病理意义。在正常组织中,TUBB3 表达较弱或缺失。相比之下,在 103 例 UTUC 病例中的 51 例(49%)尿路上皮癌组织中观察到 TUBB3 过表达。TUBB3 过表达与结节/扁平形态、高级别疾病、高 T 分期和预后不良有关。在 The Cancer Genome Atlas 膀胱癌队列中也获得了类似的结果。TUBB3 表达还与 UTUC 中的高 Ki-67 标记指数、CD44v9、HER2、EGFR 和 p53 表达有关。在代表性的癌症相关分子中,TUBB3 是无进展生存期和高级别 UC 的独立预测因子。最后,我们使用尿细胞学样本通过免疫细胞化学分析 TUBB3 表达。在 UC 细胞中比在非肿瘤细胞中更频繁地发现 TUBB3 表达。当与 TUBB3 免疫染色结合使用时,尿细胞学的诊断准确性得到提高。这些发现表明 TUBB3 在肿瘤进展中的重要性及其作为高级别疾病和 UC 预后的生物标志物的潜在应用。此外,与 TUBB3 免疫染色相结合可能会提高尿细胞学的诊断准确性。

相似文献

1
Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology.TUBB3 在尿路上皮癌中的临床病理意义及其在尿液细胞学中的可能应用。
Pathol Int. 2023 Sep;73(9):444-455. doi: 10.1111/pin.13362. Epub 2023 Aug 17.
2
MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma.MCM4 表达与尿路上皮癌的高级别组织学、肿瘤进展和不良预后相关。
Diagn Pathol. 2023 Sep 22;18(1):106. doi: 10.1186/s13000-023-01392-y.
3
Clinicopathological significance of the overexpression of MUC1 in upper tract urothelial carcinoma and possible application as a diagnostic marker.MUC1在上尿路尿路上皮癌中过表达的临床病理意义及作为诊断标志物的可能应用。
Pathol Int. 2022 Dec;72(12):606-616. doi: 10.1111/pin.13274. Epub 2022 Sep 28.
4
Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.Claspin 过表达的临床病理意义及其作为尿路上皮癌新型诊断标志物的疗效。
Virchows Arch. 2022 Mar;480(3):621-633. doi: 10.1007/s00428-021-03239-7. Epub 2021 Nov 29.
5
Dual immunocytochemical staining of annexin A10 and p53 in low-grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology.双重免疫细胞化学染色法检测 annexin A10 和 p53 在低级别和乳头状尿路上皮癌中的表达有助于提高尿细胞学诊断的准确性。
Cancer Cytopathol. 2023 Sep;131(9):548-560. doi: 10.1002/cncy.22727. Epub 2023 Jun 10.
6
Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.荧光原位杂交(FISH)在膀胱和上尿路尿路上皮癌诊断中的应用:迄今为止最大规模的单机构经验。
Can J Urol. 2017 Feb;24(1):8620-8626.
7
Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.对p53和Ki-67进行免疫细胞化学染色有助于在尿液细胞学中对尿路上皮细胞进行特征描述。
Cytopathology. 2016 Dec;27(6):456-464. doi: 10.1111/cyt.12332. Epub 2016 Mar 8.
8
Diagnosis of urinary bladder urothelial carcinoma by immunocytology with p53, MCM5, MCM2 and Ki-67 antibodies using cell blocks derived from urine.利用源自尿液的细胞块,通过使用p53、MCM5、MCM2和Ki-67抗体的免疫细胞化学方法诊断膀胱尿路上皮癌
Cytopathology. 2019 Sep;30(5):510-518. doi: 10.1111/cyt.12698. Epub 2019 May 20.
9
ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial Carcinoma.在上尿路和下尿路尿路上皮癌中,ANXA10 的表达与肿瘤分期、分级和 TP53 表达呈负相关。
Pathobiology. 2023;90(2):94-103. doi: 10.1159/000524989. Epub 2022 Jul 1.
10
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.上尿路尿路上皮癌临床病理特征的预测中,上尿路细胞学和活检的临床实用性和一致性。
Hum Pathol. 2019 Apr;86:76-84. doi: 10.1016/j.humpath.2018.11.021. Epub 2018 Dec 8.

引用本文的文献

1
Nectin-4 expression in upper and lower tract urothelial carcinoma: correlation with early-stage disease and prognostic relevance.Nectin-4在上尿路和下尿路尿路上皮癌中的表达:与早期疾病的相关性及预后意义。
Virchows Arch. 2025 Jun 27. doi: 10.1007/s00428-025-04164-9.
2
Distribution and clinicopathological characteristics of G-CSF expression in tumor cells and stromal cells in upper tract urothelial carcinoma.上尿路尿路上皮癌中肿瘤细胞和基质细胞G-CSF表达的分布及临床病理特征
J Cancer Res Clin Oncol. 2024 Dec 30;151(1):18. doi: 10.1007/s00432-024-06045-1.